All stock reports

NAGREEKCAP evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-23T14:00:41.995363+00:00

Metrics

latest_annual_period
2026-03-31
revenue
496016000.0
net_income
74117000.0
operating_cash_flow
14027000.0
free_cash_flow
89089000.0
total_assets
1448158000.0
total_liabilities
1162771000.0
total_equity
285387000.0
cash
10838000.0
total_debt
946279000.0
revenue_growth
-0.07238007252407341
earnings_growth
-0.6006971381777433
net_margin
0.14942461533498919
roe
0.2597069943620417
debt_to_equity
3.315774719941693
cash_conversion
0.18925482682785325
free_cash_flow_margin
0.17960912551208025
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Evidence unavailable. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
Decision provenance and limitations
Decision ID
decision-ad045aceefb570af5df18aaf7d09283978bb340c6e880610ba9857b80c06976e
Policy
stock-decisions-v1
Evidence bundle hash
03e783948573d2b01c1f540892906b9d00cae0fe89943ba42d28554b71df2257
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: 6ad29c60e8f70bc589867a6a6ad268647e36e67edf4339d0b2eefb79085e4807
  • daily-price: 333d98a9ede6eee2bb582f51a7491843ec84ba1ec1bb029665e762c373adc181
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Numerical report available. Evidence briefing is queued or awaiting retry.

Cached observations and evidence limits